Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

Appendiceal cancer is a rare cancer without standardized screening guidelines, risk factors or tumor classifications—a situation that often results in late diagnosis and poor prognosis.

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

Improved progression-free survival in metastatic urothelial carcinoma was observed in patients experiencing neuropathy, skin rash, and hyperglycemia following enfortumab vedotin.

Background: Neuroendocrine ... Diagnosis confirmed by pathology (4). Patients aged 18-45 years at diagnosis (5). Complete clinical data and follow-up information. Exclusion criteria (1): Patients with ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

But the terms mean the same thing. There are 2 key groups of neuroendocrine cancer: neuroendocrine tumours (NETs) neuroendocrine carcinomas (NECs) Neuroendocrine cancer can start in any part of the ...

Subepithelial lesions (SLEs) are often detected incidentally during endoscopic examination. They represent a heterogeneous ...

Early prostate cancer usually causes no symptoms, but can include blood in the urine or semen. The outlook is often excellent, especially if doctors diagnose it in the early stages. Prostate ...

It is still useful to provide pretesting likelihoods, but models need to take into account tumour pathology. Methods The Manchester Scoring System (MSS) is a well-used, simple, paper-based model for ...

more advanced tumour histology and increased metastasis. The presence of these markers in cancer cells, along with the in vivo evidence of cell fusion discussed earlier, could be explained by the ...

Understanding tumour heterogeneity is critical when developing novel treatment strategies. However, a comprehensive investigation of tumour heterogeneity in HCC is lacking, and the available evidence ...